Cargando…

A Preliminary Report on the Largest Ongoing Outbreak of Lead Toxicity in Iran

No countrywide data exists on the patients’ characteristics of lead exposure in Iran. We aimed to evaluate the demographic characteristics and blood lead level (BLL) of these patients in the country scale during five consecutive years, including the epidemic outbreak year (2016). Between 2014 and 20...

Descripción completa

Detalles Bibliográficos
Autores principales: Zamani, Nasim, Mehrpour, Omid, Hassanian-Moghaddam, Hossein, Jalali, Maryam, Amirabadizadeh, Alireza, Samie, Saeed, Sabeti, Shahram, Kolahi, Ali-Asghar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7367297/
https://www.ncbi.nlm.nih.gov/pubmed/32678122
http://dx.doi.org/10.1038/s41598-020-64859-8
_version_ 1783560396105318400
author Zamani, Nasim
Mehrpour, Omid
Hassanian-Moghaddam, Hossein
Jalali, Maryam
Amirabadizadeh, Alireza
Samie, Saeed
Sabeti, Shahram
Kolahi, Ali-Asghar
author_facet Zamani, Nasim
Mehrpour, Omid
Hassanian-Moghaddam, Hossein
Jalali, Maryam
Amirabadizadeh, Alireza
Samie, Saeed
Sabeti, Shahram
Kolahi, Ali-Asghar
author_sort Zamani, Nasim
collection PubMed
description No countrywide data exists on the patients’ characteristics of lead exposure in Iran. We aimed to evaluate the demographic characteristics and blood lead level (BLL) of these patients in the country scale during five consecutive years, including the epidemic outbreak year (2016). Between 2014 and 2018, records of all patients who had referred to two reference laboratories in Tehran, Iran, to check BLL were evaluated. Of 58,642 patients, 48,589 were male. Mean age was 44.9 ± 20.7 years. Males had higher BLLs and were significantly older. Median BLL was 16 µg/dL (0.3 to 263 µg/dL). Median BLL was significantly higher in 45- to 60-year-old patients. The highest median BLL was reported in May 2016 confirming our records about the peak of the epidemic. Although the frequency of high BLL declined after 2016, it never returned to the measures before that. Considering the ongoing high prevalence of increased BLLs after 2016 and similar environmental and occupational exposures as before, lead-contaminated opium still seems to persist in the Iranian opium black market. Substitution of this lead-contaminated opium by Opioid Maintenance Therapy (OMT)-prescribed opium tincture is recommended.
format Online
Article
Text
id pubmed-7367297
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-73672972020-07-20 A Preliminary Report on the Largest Ongoing Outbreak of Lead Toxicity in Iran Zamani, Nasim Mehrpour, Omid Hassanian-Moghaddam, Hossein Jalali, Maryam Amirabadizadeh, Alireza Samie, Saeed Sabeti, Shahram Kolahi, Ali-Asghar Sci Rep Article No countrywide data exists on the patients’ characteristics of lead exposure in Iran. We aimed to evaluate the demographic characteristics and blood lead level (BLL) of these patients in the country scale during five consecutive years, including the epidemic outbreak year (2016). Between 2014 and 2018, records of all patients who had referred to two reference laboratories in Tehran, Iran, to check BLL were evaluated. Of 58,642 patients, 48,589 were male. Mean age was 44.9 ± 20.7 years. Males had higher BLLs and were significantly older. Median BLL was 16 µg/dL (0.3 to 263 µg/dL). Median BLL was significantly higher in 45- to 60-year-old patients. The highest median BLL was reported in May 2016 confirming our records about the peak of the epidemic. Although the frequency of high BLL declined after 2016, it never returned to the measures before that. Considering the ongoing high prevalence of increased BLLs after 2016 and similar environmental and occupational exposures as before, lead-contaminated opium still seems to persist in the Iranian opium black market. Substitution of this lead-contaminated opium by Opioid Maintenance Therapy (OMT)-prescribed opium tincture is recommended. Nature Publishing Group UK 2020-07-16 /pmc/articles/PMC7367297/ /pubmed/32678122 http://dx.doi.org/10.1038/s41598-020-64859-8 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Zamani, Nasim
Mehrpour, Omid
Hassanian-Moghaddam, Hossein
Jalali, Maryam
Amirabadizadeh, Alireza
Samie, Saeed
Sabeti, Shahram
Kolahi, Ali-Asghar
A Preliminary Report on the Largest Ongoing Outbreak of Lead Toxicity in Iran
title A Preliminary Report on the Largest Ongoing Outbreak of Lead Toxicity in Iran
title_full A Preliminary Report on the Largest Ongoing Outbreak of Lead Toxicity in Iran
title_fullStr A Preliminary Report on the Largest Ongoing Outbreak of Lead Toxicity in Iran
title_full_unstemmed A Preliminary Report on the Largest Ongoing Outbreak of Lead Toxicity in Iran
title_short A Preliminary Report on the Largest Ongoing Outbreak of Lead Toxicity in Iran
title_sort preliminary report on the largest ongoing outbreak of lead toxicity in iran
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7367297/
https://www.ncbi.nlm.nih.gov/pubmed/32678122
http://dx.doi.org/10.1038/s41598-020-64859-8
work_keys_str_mv AT zamaninasim apreliminaryreportonthelargestongoingoutbreakofleadtoxicityiniran
AT mehrpouromid apreliminaryreportonthelargestongoingoutbreakofleadtoxicityiniran
AT hassanianmoghaddamhossein apreliminaryreportonthelargestongoingoutbreakofleadtoxicityiniran
AT jalalimaryam apreliminaryreportonthelargestongoingoutbreakofleadtoxicityiniran
AT amirabadizadehalireza apreliminaryreportonthelargestongoingoutbreakofleadtoxicityiniran
AT samiesaeed apreliminaryreportonthelargestongoingoutbreakofleadtoxicityiniran
AT sabetishahram apreliminaryreportonthelargestongoingoutbreakofleadtoxicityiniran
AT kolahialiasghar apreliminaryreportonthelargestongoingoutbreakofleadtoxicityiniran
AT zamaninasim preliminaryreportonthelargestongoingoutbreakofleadtoxicityiniran
AT mehrpouromid preliminaryreportonthelargestongoingoutbreakofleadtoxicityiniran
AT hassanianmoghaddamhossein preliminaryreportonthelargestongoingoutbreakofleadtoxicityiniran
AT jalalimaryam preliminaryreportonthelargestongoingoutbreakofleadtoxicityiniran
AT amirabadizadehalireza preliminaryreportonthelargestongoingoutbreakofleadtoxicityiniran
AT samiesaeed preliminaryreportonthelargestongoingoutbreakofleadtoxicityiniran
AT sabetishahram preliminaryreportonthelargestongoingoutbreakofleadtoxicityiniran
AT kolahialiasghar preliminaryreportonthelargestongoingoutbreakofleadtoxicityiniran